144 related articles for article (PubMed ID: 34238763)
1. Anoctamin 5 promotes osteosarcoma development by increasing degradation of Nel-like proteins 1 and 2.
Pan R; Lu Q; Ren C; Li H; Zeng F; Tian X; Chen H
Aging (Albany NY); 2021 Jul; 13(13):17316-17327. PubMed ID: 34238763
[TBL] [Abstract][Full Text] [Related]
2. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
3. Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer.
Fukami T; Shiozaki A; Kosuga T; Kudou M; Shimizu H; Ohashi T; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Morinaga Y; Konishi E; Otsuji E
World J Gastroenterol; 2022 Aug; 28(32):4649-4667. PubMed ID: 36157935
[TBL] [Abstract][Full Text] [Related]
4. Anoctamin5 regulates cell migration and invasion in thyroid cancer.
Chang Z; Cai C; Han D; Gao Y; Li Q; Feng L; Zhang W; Zheng J; Jin J; Zhang H; Wei Q
Int J Oncol; 2017 Oct; 51(4):1311-1319. PubMed ID: 28902351
[TBL] [Abstract][Full Text] [Related]
5. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
6. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma.
Nakamura R; Oyama T; Tajiri R; Mizokami A; Namiki M; Nakamoto M; Ooi A
Cancer Sci; 2015 May; 106(5):656-64. PubMed ID: 25726761
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
[TBL] [Abstract][Full Text] [Related]
9. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA SNHG12 reversed IGF1R-induced osteosarcoma metastasis and proliferation by targeting miR-195-5p.
Xu N; Xu J; Zuo Z; Liu Y; Yan F; Han C
Gene; 2020 Feb; 726():144145. PubMed ID: 31743769
[TBL] [Abstract][Full Text] [Related]
11. Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma.
Dai F; Luo F; Zhou R; Zhou Q; Xu J; Zhang Z; Xiao J; Song L
Aging (Albany NY); 2020 Jul; 12(14):14037-14049. PubMed ID: 32667904
[TBL] [Abstract][Full Text] [Related]
12. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
[TBL] [Abstract][Full Text] [Related]
14. DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.
Wang L; Liu W; Tang H; Xie X; Zou C; Wang Y; Gao Z; Yin J
Cancer Med; 2017 May; 6(5):982-993. PubMed ID: 28374915
[TBL] [Abstract][Full Text] [Related]
15. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3.
Tan Y; Chen L; Li S; Hao H; Zhang D
Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151
[TBL] [Abstract][Full Text] [Related]
16. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
17. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.
Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y
Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909
[TBL] [Abstract][Full Text] [Related]
18. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
[TBL] [Abstract][Full Text] [Related]
19. Upregulation and biological function of transmembrane protein 119 in osteosarcoma.
Jiang ZH; Peng J; Yang HL; Fu XL; Wang JZ; Liu L; Jiang JN; Tan YF; Ge ZJ
Exp Mol Med; 2017 May; 49(5):e329. PubMed ID: 28496199
[TBL] [Abstract][Full Text] [Related]
20. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
Qin Y; Ye J; Zhao F; Hu S; Wang S
Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
